HER-2/neu Assessment in Breast Cancer by Immunohistochemistry and Fluorescence In Situ Hybridization: Comparison of Results and Correlation With Survival

被引:0
|
作者
Sanjay Kakar
Nick Puangsuvan
Jane M. Stevens
Romualda Serenas
George Mangan
Shalini Sahai
Michael L. Mihalov
机构
[1] University of Illinois at Chicago,Department of Pathology
关键词
prognosis; Herceptin;
D O I
10.1007/BF03262077
中图分类号
学科分类号
摘要
Background: HER-2/neu immunohistochemistry (IHC) and fluorescence insitu hybridization (FISH) results guide breast cancer therapy; however, few studies compared the results and no published studies have correlated them with patient outcome.
引用
收藏
页码:199 / 207
页数:8
相关论文
共 50 条
  • [1] HER-2/neu assessment in breast cancer by immunohistochemistry and fluorescence in situ hybridization:: Comparison of results and correlation with survival
    Kakar, S
    Puangsuvan, N
    Stevens, JM
    Serenas, R
    Mangan, G
    Sahai, S
    Mihalov, ML
    MOLECULAR DIAGNOSIS, 2000, 5 (03): : 199 - 207
  • [2] Correlation of Her-2/neu results by immunohistochemistry and fluorescence in situ hybridization with survival in breast cancer.
    Kakar, S
    Puangsuvan, N
    Mihalov, ML
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2000, 114 (04) : 656 - 656
  • [3] Comparison of fluorescence in situ hybridization and immunohistochemistry for the evaluation of HER-2/neu in breast cancer
    Jacobs, TW
    Gown, AM
    Yaziji, H
    Barnes, MJ
    Schnitt, SJ
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (07) : 1974 - 1982
  • [4] Comparison of fluorescence in situ hybridization and immunohistochemistry for assessment of HER-2 status in breast cancer patients
    Lin Wang
    Xiaobei Wang
    Xiu Nie
    Ling Ma
    Journal of Huazhong University of Science and Technology [Medical Sciences], 2009, 29 : 354 - 358
  • [5] Comparison of Fluorescence in situ Hybridization and Immunohistochemistry for Assessment of HER-2 Status in Breast Cancer Patients
    Wang, Lin
    Wang, Xiaobei
    Nie, Xiu
    Ma, Ling
    JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES, 2009, 29 (03) : 354 - 358
  • [6] Comparison of Fluorescence in situ Hybridization and Immunohistochemistry for Assessment of HER-2 Status in Breast Cancer Patients
    王琳
    王晓蓓
    聂秀
    马玲
    Current Medical Science, 2009, 29 (03) : 354 - 358
  • [7] The role of immunohistochemistry and fluorescence in situ hybridization for HER-2/neu in assessing the prognosis of breast cancer
    Mitchell, MS
    Press, MF
    SEMINARS IN ONCOLOGY, 1999, 26 (04) : 108 - 116
  • [8] Comparison of immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) assessment for Her-2 status in breast cancer
    Sui, Weiguo
    Ou, Minglin
    Chen, Jiejing
    Wan, Youhua
    Peng, Hongbo
    Qi, Minfang
    Huang, He
    Dai, Yong
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2009, 7 : 83
  • [9] Comparison of immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) assessment for Her-2 status in breast cancer
    Weiguo Sui
    Minglin Ou
    Jiejing Chen
    Youhua Wan
    Hongbo Peng
    Minfang Qi
    He Huang
    Yong Dai
    World Journal of Surgical Oncology, 7
  • [10] HER-2/neu analysis in archival tissue samples of human breast cancer:: Comparison of immunohistochemistry and fluorescence in situ hybridization
    Lebeau, A
    Deimling, D
    Kaltz, C
    Sendelhofert, A
    Iff, A
    Luthardt, B
    Untch, M
    Löhrs, U
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (02) : 354 - 363